Researchers works. Through the blood, it is that countless

Researchers from the Department of Physical and Inorganic Chemistry of the URV, led by the ICREA researcher Ramon Alvarez Puebla and by the professor of Applied Physics Francisco Díaz, and the Department of Clinical Oncology of the Hospital Universitario HM Torrelodones, have patented a portable device that detects cells tumor in the blood.The device quantifies the number of tumor cells in a blood sample, one at a time and in real time. Therefore, it is a tool that allows a medical instrument that improves the efficiency of cancer monitoring, treatment and diagnosis, since it can now be done simply by acquiring a blood sample.All research advances that promote a better quality of life for patients with cancer, it is necessary to know at the stage where the person is that makes you can plan your life more, as well as, to prevent situations that create more family suffering hopes that can no longer exist. Being aware of how your progress is going, of what you must do or not, are few of the things that can be said in this difficult but real situation. The vascular system is a powerful weapon in our body and every time we get deeper into it, we will learn more how our body works. Through the blood, it is that countless processes are carried out and it is the transport route for all our organs. This device allows rapid, economical, effective and less aggressive analysis, reducing the discomfort of patients, identifies the disease in advance and allows monitoring of tumors.The Center for Biomedical Research in Cancer Network (CIBERONC), through the research group led by Xosé R. Bustelo, also belonging to the Cancer Research Center of Salamanca, has just discovered that the VAV1 gene, usually involved in training of a wide range of tumors, may also play roles in the suppression of some specific types of acute lymphoblastic leukemia of T lymphocytes. This leukemia is the most frequent pediatric cancer and, even today, has many challenges for an adequate diagnosis and treatment.T-lymphocytes are cells of the immune system whose function is the recognition and destruction of cells from our organs that have become cancerous or that have been infected by viruses or other pathogens. They are also in charge of regulating other cells of the immune system involved in the destruction of any external agent that invades our body such as chemicals or bacteria.In this research you can develop appropriate therapies that allow the elimination of cancer cells.When a patient suffers from cancer of the hematological cells, there is a predominance of immature precursor cells of the lymphocytes, it will be classified as a pathology like an acute lymphatic leukemia.The discovery of new ways to treat leukemia is an important area, as this would raise the cure rate for children in the future. Other new treatments – antibodies, chemotherapy and other biologically active treatments – are being studied in the hope that they will increase the cure rate and / or decrease the likelihood of side effects.Referenceshttp://biotech-spain.com/articles/develop-a-device-detecta-c-tules-tumorales-en-la-sangre/http://biotech-spain.com/en/articles/identified-a-new-mechanism-that-freely-the-formation-of-species-of-the-blood-/https://www.cancer.net/es/tipos-de-c%C3%A1ncer/leucemia-linfobl%C3%A3stica-aguda-all-infantil/s%C3%ADntomas-y-signosMarilyn Andreu